1786 – FreeStyle Libre 2 continuous glucose monitoring system for people with insulin dependent type 2 diabetes, gestational diabetes and type 3c diabetes

Page last updated: 27 September 2024

Application Detail

Description of Medical Service

FreeStyle Libre 2 continuous glucose monitoring system (FSL2) is a monitoring system with two key components: a disposable 14-day sensor (inserted into subcutaneous tissue at the back of the upper arm) and a reader (using either a smartphone application or a physical reader). This sensor includes an inbuilt transmitter that transmits glucose data to the application or reader. It is designed to continuously measure glucose levels in the interstitial fluid and provides glucose trends, variability, and patterns across a 24-hour period.This helps people with type 2 diabetes (T2D) to manage their condition and reduce the risk of diabetes-related complications.

Description of Medical Condition

T2D is a condition in which the body becomes resistant to the normal effects of insulin and gradually loses the capacity to produce enough insulin in the pancreas. This leads to high blood sugar (glucose) levels. T2D is the most common form of diabetes and is more likely to occur in those with a family history of the condition, although its development can also be associated with lifestyle factors.

Initially, T2D can often be managed with lifestyle modification such as healthy eating and regular exercise. However, many people with T2D will also need to take medication and many eventually require insulin injections to reduce the complications associated with the condition such as nerve damage, kidney disease and heart disease.

Reason for Application

National Diabetes Services Scheme funding

Medical Service Type

Investigative technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Summary and PICO Set

Application Summary (PDF 213 KB)
Application Summary (Word 32 KB)

Application PICO Set (PDF 1014 KB)
Application PICO Set (Word 1531 KB)

Consultation Survey

Consultation Survey

PASC Consultation
PASC consultation closes Friday 8 November 2024. Any consultation received after this date will automatically be included in the MSAC consultation for this application.

MSAC Consultation
MSAC consultation TBA – please subscribe to the MSAC email bulletin to be notified when this application is scheduled for MSAC consideration. The bulletin will also advise the closing date for consultation input.

For further information please refer to PASC, ESC, MSAC Key Dates

For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

12-13 December 2024

ESC

-

MSAC

-